Envestnet Asset Management Inc. Has $33.49 Million Stake in Koninklijke Philips N.V. (NYSE:PHG)

Envestnet Asset Management Inc. lessened its stake in shares of Koninklijke Philips N.V. (NYSE:PHG - Free Report) by 3.6% in the first quarter, according to its most recent filing with the SEC. The fund owned 1,318,352 shares of the technology company's stock after selling 49,666 shares during the period. Envestnet Asset Management Inc. owned about 0.14% of Koninklijke Philips worth $33,486,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. Colonial Trust Co SC lifted its position in shares of Koninklijke Philips by 724.0% during the 4th quarter. Colonial Trust Co SC now owns 1,409 shares of the technology company's stock valued at $36,000 after acquiring an additional 1,238 shares during the last quarter. Bessemer Group Inc. lifted its position in shares of Koninklijke Philips by 2,935.4% during the 1st quarter. Bessemer Group Inc. now owns 1,973 shares of the technology company's stock valued at $51,000 after acquiring an additional 1,908 shares during the last quarter. Farther Finance Advisors LLC lifted its holdings in shares of Koninklijke Philips by 37.1% in the fourth quarter. Farther Finance Advisors LLC now owns 2,150 shares of the technology company's stock valued at $54,000 after purchasing an additional 582 shares in the last quarter. Millstone Evans Group LLC purchased a new stake in shares of Koninklijke Philips in the fourth quarter valued at $60,000. Finally, Castlekeep Investment Advisors LLC purchased a new stake in shares of Koninklijke Philips in the fourth quarter valued at $114,000. Institutional investors and hedge funds own 13.67% of the company's stock.

Koninklijke Philips Stock Up 1.0%

Shares of NYSE:PHG traded up $0.26 during midday trading on Thursday, hitting $24.64. 843,143 shares of the stock were exchanged, compared to its average volume of 906,881. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.79 and a current ratio of 1.28. Koninklijke Philips N.V. has a 52-week low of $20.61 and a 52-week high of $31.57. The business's fifty day simple moving average is $23.58 and its two-hundred day simple moving average is $24.94. The company has a market capitalization of $23.72 billion, a PE ratio of 57.29, a P/E/G ratio of 0.69 and a beta of 0.76.

Koninklijke Philips (NYSE:PHG - Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The technology company reported $0.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.14 by $0.13. The business had revenue of $4.31 billion during the quarter, compared to analyst estimates of $4.10 billion. Koninklijke Philips had a return on equity of 10.97% and a net margin of 2.11%. Koninklijke Philips's quarterly revenue was down 1.0% compared to the same quarter last year. During the same period last year, the company earned $0.21 earnings per share. As a group, research analysts predict that Koninklijke Philips N.V. will post 1.63 earnings per share for the current fiscal year.

Analyst Ratings Changes

Separately, Wall Street Zen upgraded Koninklijke Philips from a "hold" rating to a "buy" rating in a report on Saturday, July 12th. One equities research analyst has rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock has an average rating of "Buy".

Koninklijke Philips Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.